Skip to main content
. Author manuscript; available in PMC: 2019 Apr 29.
Published in final edited form as: Breast Cancer Res Treat. 2018 May 29;171(2):261–271. doi: 10.1007/s10549-018-4839-2

Table 1.

Associations of MALAT1 expression with clinical and pathological factors of breast cancer

Variables Total No. (N=509) MALAT1 expression
P value
Low No. (%) Mid No. (%) High No. (%)
Age at Surgery (year)
≤57.80 253 (49.90)  88 (34.78)  86 (33.99)  79 (31.23) 0.57
>57.80 254 (50.10) 78 (30.71) 88 (34.65) 88 (34.65)
Disease Stage 0.30
Stage 1 168 (34.93) 49 (29.17) 53 (31.55) 66 (39.29)
Stage 2 241 (50.10) 83 (34.44) 78 (32.37) 80 (33.20)
Stage 3 & 4 72 (14.96) 24 (33.33) 32 (44.44) 16 (22.22)
Tumor Grade 0.013
Grade 1 60 (12.12) 13 (21.67) 19 (31.67) 28 (46.67)
Grade 2 192 (38.79) 50 (26.04) 65 (33.85) 77 (40.10)
Grade 3 243 (49.09) 101 (41.56) 83 (34.16) 59 (24.28)
ER Status 0.0002
Positive 349 (70.08) 97 (27.79) 122 (34.96) 130 (37.25)
Negative 149 (29.92) 68 (45.64) 48 (32.21) 33 (22.15)
PR Status <0.0001
Positive 295 (59.36) 75 (25.42) 111 (37.63) 109 (36.95)
Negative 202 (40.64) 89 (44.06) 59 (29.21) 54 (26.73)